Characterization of Enterobacteriaceae Isolates Obtained from a Tertiary Care Hospital in Mexico, Which Produces Extended-Spectrum β-Lactamase

Microbial Drug Resistance

Volumn 19, Issue 5, 2013, Pages 378-383

  Morfín Otero, Rayo ^a   Mendoza Olazarán, Soraya ^b   Silva Sánchez, Jesús ^c   Rodríguez Noriega, Eduardo ^a   Laca Díaz, Jorge ^b   Tinoco Carrillo, Perla ^c   Petersen, Luis ^a   López, Perla ^d   Reyna Flores, Fernando ^c   Alcantar Curiel, Dolores ^e   Garza Ramos, Ulises ^c   Garza González, Elvira ^b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d Medicina UANL   (Mexico)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLARITHROMYCIN PLUS LANSOPRAZOLE; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NITROFURANTOIN; NORFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BROTH DILUTION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HOSPITAL; HOSPITAL INFECTION; KLEBSIELLA PNEUMONIAE; MEXICO; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; INFANT; INFANT, NEWBORN; KLEBSIELLA PNEUMONIAE; MALE; MEXICO; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; TERTIARY HEALTHCARE;

EID: 84884561743     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2012.0263     Document Type: Article

References (19)

1. Alcantar-Curiel D., J.C. Tinoco, C. Gayosso, A. Carlos, C. Daza, M.C. Perez-Prado, L. Salcido, J.I. Santos, and C.M. Alpuche-Aranda. 2004. Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes. Clin Infect Dis 38:1067-1074
2. Barrios H., U. Garza-Ramos, L.E. Ochoa-Sanchez, F. Reyna-Flores, T. Rojas-Moreno, R. Morfin-Otero, E. Rodriguez-Noriega, E. Garza-Gonzalez, G. Gonzalez, P. Volkow, et al. 2012. Aplasmid-encoded class 1 integron contains GES-Type extended-spectrum beta-lactamases in Enterobacteriaceae clinical isolates in Mexico. Antimicrob Agents Chemother 56:4032-4034
3. Bonnet R. 2004. Growing group of extended-spectrum betalactamases: The CTX-M enzymes. Antimicrob Agents Chemother 48:1-14
4. Bradford P.A. 2001. Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14:933-951, table of contents
5. Garza-Gonzalez E., S.I. Mendoza Ibarra, J.M. Llaca-Diaz, and G.M. Gonzalez. 2011. Molecular characterization and antimicrobial susceptibility of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae isolates at a tertiarycare centre in Monterrey, Mexico. J Med Microbiol 60:84-90
6. Institute C.A.L.S. 2012. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Second Informational Supplement. C.A.L.S, Wayne, PA: M100-S22
7. Johnson J.R., C. Urban, S.J. Weissman, J.H. Jorgensen, J.S. Lewis, 2nd, G. Hansen, P.H. Edelstein, A. Robicsek, T. Cleary, J. Adachi, et al. 2012. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-beta-lactamaseproducing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother 56:2364-2370
8. Kaufmann M.E. 1998. Pulsed-field gel electrophoresis. Methods Mol Med 15:33-50
9. Kieser T. 1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19-36
10. Kiratisin P., A. Apisarnthanarak, C. Laesripa, and P. Saifon. 2008. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase- producing Escherichia coli and Klebsiella pneumoniae isolates causing health careassociated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 52:2818-2824
11. Magiorakos A.P., A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, C.G. Giske, S. Harbarth, J.F. Hindler, G. Kahlmeter, B. Olsson-Liljequist, et al. 2012. Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268-281
12. Mosqueda-Gomez J.L., A. Montano-Loza, A.L. Rolon, C. Cervantes, J.M. Bobadilla-Del-Valle, J. Silva-Sanchez, U. Garza-Ramos, A. Villasis-Keever, A. Galindo-Fraga, G.M. Palacios, et al. 2008. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A casecontrol study. Int J Infect Dis 12:653-659
13. Peirano G., A.K. van der Bij, D.B. Gregson, and J.D. Pitout. 2012. Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum beta-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region. J Clin Microbiol 50:294-299
14. Poirel L., M. Gniadkowski, and P. Nordmann. 2002. Biochemical analysis of the ceftazidime-hydrolysing extendedspectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. JAntimicrob Chemother 50:1031-1034
15. Sennati S., G. Santella, J. Di Conza, L. Pallecchi, M. Pino, B. Ghiglione, G.M. Rossolini, M. Radice, and G. Gutkind. 2012. Changing Epidemiology of Extended-Spectrum beta-Lactamases in Argentina: Emergence of CTX-M-15. Antimicrob Agents Chemother 56:6003-6005
16. Silva-Sanchez J., H. Barrios, F. Reyna-Flores, M. Bello-Diaz, A. Sanchez-Perez, T. Rojas, and U. Garza-Ramos. 2011. Prevalence and characterization of plasmid-mediated quinolone resistance genes in extended-spectrum betalactamase-producing Enterobacteriaceae isolates in Mexico. Microb Drug Resist 17:497-505
17. Silva-Sanchez J., J.U. Garza-Ramos, F. Reyna-Flores, A. Sanchez-Perez, T. Rojas-Moreno, V. Andrade-Almaraz, J. Pastrana, J.I. Castro-Romero, P. Vinuesa, H. Barrios, et al. 2011. Extended-spectrum beta-lactamase-producing enterobacteriaceae causing nosocomial infections in Mexico. A retrospective and multicenter study. Arch Med Res 42: 156-162
18. Siu L.K., P.L. Lu, P.R. Hsueh, F.M. Lin, S.C. Chang, K.T. Luh, M. Ho, and C.Y. Lee. 1999. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: Clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol 37:4020-4027
19. Tenover F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 33:2233-2239